Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled novel APC variants in six families, explaining mis..
Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first-trimester spontaneous pregnancy loss [1]. The aim..
Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the mom's blood that indicate labor and even early bi..
A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized therapy for cancer patients by integrating genetic wi..
Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are estimated to affect approximately 1 in 150 live bi..
Mitochondria, those cellular powerhouses, are at the heart of metabolic activities. Recent research reveals a one-sided transfer of mitochondria from T cells to cancer cells, a process that strengthe..
Have you ever wondered how jet-setting across the globe might affect your gut health? A recent study has dug into this intriguing question, revealing that travel can have some unexpected impacts on t..
Genetic variant databases are vital for interpreting genetic variations in clinical settings and research. However, misclassified variants can create challenges. A recent study analyzed archives of C..
The ClinGen Sequence Variant Interpretation Working Group has published recommendations on how to evaluate splicing variant data, offering standardized guidance on evidence codes and functional data ..
Exciting news in genetic research! The Human Pangenome Reference Consortium has unveiled an improved version of the human pangenome reference. This comprehensive reference includes genetic informatio..
Medicover Genetics’ technology transfer platform offers comprehensive testing in a single sequencing run, making it a unique and efficient solution for laboratories of any size. With our Technology Transfer platform, laboratories can perform multi-disciplinary genetic tests such as NIPT, cardiac, hereditary cancer, carrier screening, and metabolic testing all in a single sequencing run. This improves turnaround time and reduces operational costs while ensuring high-quality results with no compromise on accuracy. Our comprehensive testing approach is ideal for laboratories looking to provide a wide range of genetic tests to their healthcare associates and patients.
Our Technology Transfer platform workflow is designed to minimize the risk of errors, reduce hands-on processing and increase the accuracy of test results, providing confidence to patients and physicians in making informed decisions with our user-friendly protocols. The implementation of these protocols ensures that laboratory personnel are trained to follow standardized procedures, reducing the likelihood of human error, and increasing the quality of results.
Medicover Genetics’ versatile Technology Transfer platform can be integrated in a single workflow, offering a multidisciplinary portfolio of genetic tests. VERACITY, VERACITY High Content (HC) and TarCET IVD kits are CE-marked and include user friendly color identification formatting. VERACITY and VERACITY HC kits contain 96 reactions and TarCET IVD kits contain 16 reactions.
We work closely with laboratories to meet their unique needs and goals. We understand that every laboratory is different, and we tailor our approach to accommodate the specific requirements of each partner. In collaboration with our partners, we design a seamless integrated process, from initial setup to ongoing support and maintenance. Our experienced team provides technical, commercial, and marketing assistance to ensure a successful partnership and optimal performance. We aim to build long-lasting partnerships that are mutually beneficial.
